The DOI matches its Crossref record.
Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis.
Abstract
We have derived a panel of CD4+, TCR-alpha/beta + T cell clones from SJL (H-2s) mice specific for an encephalitogenic determinant of myelin proteolipid protein (PLP) 139-151 (HSLGKWLGHPDKF). All the clones are Ag specific and IAs restricted, but they show heterogeneity in their ability to induce experimental allergic encephalomyelitis (EAE), i.e., one group induces EAE in naive mice, a second group induces disease only in mice that are pretreated with pertussis and irradiation, whereas a third group is essentially nonencephalitogenic. To determine the basis for this functional heterogeneity, the clones were tested for the expression of adhesion molecules and cytokines and for Ag-specific cytolytic activity. All of the clones expressed comparable levels of LFA-1 and CD44 but lacked expression of Mel 14. However, those clones that induced EAE only in irradiation- and pertussis-treated recipients did not express VLA4. Because pretreatment with pertussis has been suggested to increase permeability of the blood-brain barrier and facilitate migration of T cells into the central nervous system, the absence of VLA4 on this group of clones may account for the need for pretreatment to induce EAE. The nonencephalitogenic clones expressed all of the adhesion molecules tested but were not cytolytic in vitro and failed to produce one or more of the proinflammatory cytokines after Ag-specific stimulation. One nonencephalitogenic clone that did not produce many cytokines on activation with specific Ag, however, could be activated with Con A to express mRNA for most cytokines and this was accompanied by a concomitant change in the encephalitogenic potency of this clone. These results suggest that adhesion molecules and cytokines both play a critical role in the encephalitogenicity of PLP peptide-specific T cell clones. Furthermore, the nonencephalitogenicity of some clones may be related to a defect in Ag-mediated activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Kuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., & Glimcher, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90349-6 · Cited by 1,641
Self-citationThree or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Cytokines in inflammatory brain lesions: helpful and harmful
Merrill, J. E., & Benveniste, E. N. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10047-3 · Cited by 722
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., & Röcken, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1961 · Cited by 594
Huang, D., Wang, J., Kivisakk, P., Rollins, B. J., & Ransohoff, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.713 · Cited by 583
Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3299 · Cited by 556
Self-citationPrevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
Leonard, J. P., Waldburger, K. E., & Goldman, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.381 · Cited by 547
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Self-citationWindhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., & Hafler, D. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1985 · Cited by 463
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Gómez, E. C., Sweenie, C. H., Hao, Y., Freitas, A. A., Steinhoff, U., Anderton, S. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4763 · Cited by 436
“IF N - γ (n g/ m l) MOG(35-55) (μg/ml) 0 20 30 40 10 0 20 40 50”
BackgroundMethodInfluentialAn altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., & Kuchroo, V. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90169-8 · Cited by 412
Self-citationPD-L1hi B cells are critical regulators of humoral immunity
Khan, A. R., Hams, E., Floudas, A., Sparwasser, T., Weaver, C. T., & Fallon, P. G. (2015) · Nature Communications · doi:10.1038/ncomms6997 · Cited by 387
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
Martin, R., McFarland, H. F., & Boggs, J. M. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084683 · Cited by 376
Angeles Muñoz-Fernández, M., & Fresno, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00045-8 · Cited by 367
Vajkoczy, P., Laschinger, M., & Engelhardt, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12440 · Cited by 357
Chemokine expression in murine experimental allergic encephalomyelitis
Godiska, R., Chantry, D., Dietsch, G. N., & Gray, P. W. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00008-p · Cited by 353
Stüve, O., Dooley, N. P., Uhm, J. H., Antel, J. P., Francis, G. S., Yong, V. W., & Williams, G. (1996) · Annals of Neurology · doi:10.1002/ana.410400607 · Cited by 348
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
Sommer, N., Löschmann, P.-A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., et al. (1995) · Nature Medicine · doi:10.1038/nm0395-244 · Cited by 345
Interferon beta in the treatment of multiple sclerosis: Mechanisms of action
Wee Yong, V., Chabot, S., Stuve, O., & Williams, G. (1998) · Neurology · doi:10.1212/wnl.51.3.682 · Cited by 344
Bebo, B. F., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2080 · Cited by 341
Bettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336
Self-citationLate Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Moutsopoulos, N. M., Konkel, J., Sarmadi, M., Eskan, M. A., Wild, T., Dutzan, N., Abusleme, L., Zenobia, C., Hosur, K. B., Abe, T., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007696 · Cited by 303
Adhesion molecule expression and regulation on cells of the central nervous system
Lee, S. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00084-3 · Cited by 296
Chemokine and chemokine receptor expression in the central nervous system
Hesselgesser, J., & Horuk, R. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029741 · Cited by 284
Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
Jäger, A., & Kuchroo, V. K. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02432.x · Cited by 282
Self-citationEstriol ameliorates autoimmune demyelinating disease: Implications for multiple sclerosis
Kim, S., Liva, S. M., Dalal, M. A., Verity, M. A., & Voskuhl, R. R. (1999) · Neurology · doi:10.1212/wnl.52.6.1230 · Cited by 268
Matsumoto, M., Fujii, Y., Baba, A., Hikida, M., Kurosaki, T., & Baba, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.016 · Cited by 263
Ito, A., Bebo, B. F., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.542 · Cited by 254
Hayashi, M., Luo, Y., Laning, J., Strieter, R. M., & Dorf, M. E. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00064-9 · Cited by 226
Self-citationEngelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., & Hoch, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4271 · Cited by 203
“It has been proposed that surface expression of a 4-integrin correlates with the encephalitogenic potential of murine PLP- or MBP-specific T cell clones (16, 17).”
BackgroundLampropoulou, V., Calderon‐Gomez, E., Roch, T., Neves, P., Shen, P., Stervbo, U., Boudinot, P., Anderton, S. M., & Fillatreau, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00855.x · Cited by 130
Li, Z., Korhonen, E. A., Merlini, A., Strauss, J., Wihuri, E., Nurmi, H., Antila, S., Paech, J., Deutsch, U., Engelhardt, B., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130308 · Cited by 52
Bebo, B. F., & Linthicum, D. S. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00113-5 · Cited by 51
Ten years of proteomics in multiple sclerosis
Farias, A. S., Pradella, F., Schmitt, A., Santos, L. M. B., & Martins‐de‐Souza, D. (2014) · PROTEOMICS · doi:10.1002/pmic.201300268 · Cited by 40
Metadata
- Authors
- Kuchroo, V. K., Martin, C. A., Greer, J. M., Ju, S. T., Sobel, R. A., & Dorf, M. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-10
- Volume
- 151
- Issue
- 8
- Pages
- 4371-4382
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2136806464
- Cited by
- 276
- References
- 0
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.